The latest news stories from Science Magazine about the COVID-19 crisis. Reported with support from the Pulitzer Center.
Billionaire scientist and businessman Patrick Soon-Shiong announced in a 27 May investor call and press release that an experimental vaccine being developed by two of his companies is on the shortlist of 14 candidates being evaluated by Operation Warp Speed.
Scientists are learning more about “superspreading events,” gatherings where COVID-19 clusters are likely to occur.
A demoted pandemic official expressed concern about the safety of an unproven coronavirus drug, according to a whistleblower complaint.
Most of the money in the House bill would be used to support research on COVID-19 or to offset its impact on federally funded research activities.
The U.S. government's Operation Warp Speed plans to have 300 million doeses of a COVID-19 vaccine for the United States by January 2021. Scientists and participants in existing initiatives to develop a vaccine note myriad logistical and ethical concerns with the outlined plan.
The international alarm about the COVID-19 pandemic was sounded first not by a human, but by a computer.
Science interviewed David King, a chemist who has criticized the way scientific advice has been handled by the Conservative U.K. government during the coronavirus pandemic.
Environmentalists in India are criticizing government moves to continue to approve major industrial projects.
Madagascar’s President Andry Rajoelina has expressed an interest in an unproven treatment.
Physicians are grappling with trying to carry out large, international trials in the midst of coronavirus lockdowns.
One of the first people to be diagnosed with COVID-19 in the United States hopes a legacy of her nightmare—the antibodies it left in her blood—will lead to a drug that can help others infected with the virus.